Search Videos and More
Integrating Academic Medicine into Community Oncology
Suzanne Cole, M.D., shares how her passion for community-based cancer care informed her strategy for improving patient recruitment in clinical trials.Expert Dermatology Care for Cancer Patients
The Oncodermatology Clinic at Simmons Cancer Center specializes in skincare for cancer patients, treating chemo rashes, post-surgery scarring and more common issues.Drug Developed by UTSW Spinoff Now Approved for Metastatic Kidney Cancer
The FDA has expanded its approval of belzutifan, a new kidney cancer drug, to treat metastatic renal cancer. Learn about UTSW’s role, from gene discovery to drug development.Nanoparticles developed at UTSW effectively fight tumors
Activating a specific pathway in a subset of immune cells eradicates immunologically ‘cold’ tumors, UTSW study showsLung cancer treatment shows promise in tumor models
UT Southwestern study uses 6-thio-dG molecule to damage DNA and halt spread of small cell lung cancerWhy Cancer Care Specialization Matters: The Story of a CLL Survivor
After undergoing a routine physical in September 2015, William Marks was diagnosed with chronic lymphocytic leukemia (CLL). Following an initial consultation with an oncologist, Mr. Marks left feeling more bewildered and distressed than when he first received his diagnosis.UTSW Simmons Cancer Center Welcomes New Deputy Director for Clinical Affairs
UT Southwestern welcomes Jason B. Fleming, M.D., FACS, as Deputy Director for Clinical Affairs of the Harold C. Simmons Comprehensive Cancer Center. An internationally recognized surgical oncologist specializing in the treatment of pancreatic cancer, Dr. Fleming rejoins UT Southwestern from the Moffitt Cancer Center in Tampa, Fla., where he was Chair of Gastrointestinal Oncology.Simmons Cancer Center awarded nearly $19 million in CPRIT funding
The Cancer Prevention and Research Institute of Texas (CPRIT) awarded nearly $13 million in grants to scientists and physicians at UT Southwestern this year for academic research and prevention efforts, plus $6 million for recruitment.The Target | Department of Radiation Oncology - Winter 2023
The Department of Radiation Oncology at UT Southwestern continues to blaze forward in all aspects of cancer care, including several highlights featured in this issue.Wendy and Emery Reves International Breast Cancer Symposium
Friday, May 3, 2024 | T. Boone Pickens Biomedical Building at UT Southwestern Medical CenterA Beacon of Hope in the Fight against Pancreatic Cancer
Picture yourself embarking on a challenging mountain climbing expedition despite having no prior experience. You’re not alone; a dedicated team of experts stands ready to assist.DARTBOARD daily adaptive radiotherapy concludes accrual with positive interim results
DARTBOARD (STU2021-0401: A Prospective Randomized Phase II Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer), an innovative, first-of-its-kind clinical trial, is now complete.